256 related articles for article (PubMed ID: 27866327)
1. Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.
Hajkova M; Hermankova B; Javorkova E; Bohacova P; Zajicova A; Holan V; Krulova M
Stem Cell Rev Rep; 2017 Feb; 13(1):104-115. PubMed ID: 27866327
[TBL] [Abstract][Full Text] [Related]
2. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.
Eggenhofer E; Renner P; Soeder Y; Popp FC; Hoogduijn MJ; Geissler EK; Schlitt HJ; Dahlke MH
Transpl Immunol; 2011 Sep; 25(2-3):141-7. PubMed ID: 21704160
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A promotes the therapeutic effect of mesenchymal stem cells on transplantation reaction.
Hajkova M; Jaburek F; Porubska B; Bohacova P; Holan V; Krulova M
Clin Sci (Lond); 2019 Nov; 133(21):2143-2157. PubMed ID: 31654074
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs.
Girdlestone J; Pido-Lopez J; Srivastava S; Chai J; Leaver N; Galleu A; Lombardi G; Navarrete CV
Cytotherapy; 2015 Sep; 17(9):1188-99. PubMed ID: 26276002
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
[TBL] [Abstract][Full Text] [Related]
6. Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.
Kim YH; Wee YM; Choi MY; Lim DG; Kim SC; Han DJ
Mol Med; 2011; 17(7-8):697-708. PubMed ID: 21365122
[TBL] [Abstract][Full Text] [Related]
7. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells.
Buron F; Perrin H; Malcus C; Héquet O; Thaunat O; Kholopp-Sarda MN; Moulin FT; Morelon E
Transplant Proc; 2009 Oct; 41(8):3347-52. PubMed ID: 19857747
[TBL] [Abstract][Full Text] [Related]
9. Multipotent mesenchymal stromal cells in kidney transplant recipients: The next big thing?
Sergeant E; Buysse M; Devos T; Sprangers B
Blood Rev; 2021 Jan; 45():100718. PubMed ID: 32507576
[TBL] [Abstract][Full Text] [Related]
10. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
[TBL] [Abstract][Full Text] [Related]
12. Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.
Morelon E; Lefrançois N; Besson C; Prévautel J; Brunet M; Touraine JL; Badet L; Touraine-Moulin F; Thaunat O; Malcus C
Transpl Immunol; 2010 May; 23(1-2):53-8. PubMed ID: 20406686
[TBL] [Abstract][Full Text] [Related]
13. The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells.
Javorkova E; Vackova J; Hajkova M; Hermankova B; Zajicova A; Holan V; Krulova M
Biomed Pharmacother; 2018 Jan; 97():402-411. PubMed ID: 29091890
[TBL] [Abstract][Full Text] [Related]
14. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil.
Miroux C; Morales O; Ouaguia L; Aoudjehane L; Boleslawski E; Pancré V; de Launoit Y; Calmus Y; Conti F; Delhem N
Transplant Proc; 2012 Nov; 44(9):2834-9. PubMed ID: 23146536
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.
Powell N; Till S; Bungre J; Corrigan C
J Allergy Clin Immunol; 2001 Dec; 108(6):915-7. PubMed ID: 11742267
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell effects on T-cell effector pathways.
Duffy MM; Ritter T; Ceredig R; Griffin MD
Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
[TBL] [Abstract][Full Text] [Related]
18. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.
Hoogduijn MJ; Roemeling-van Rhijn M; Korevaar SS; Engela AU; Weimar W; Baan CC
Hum Gene Ther; 2011 Dec; 22(12):1587-91. PubMed ID: 21732766
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive drugs affect induction of IFNy+ Treg in vitro.
Daniel V; Trojan K; Opelz G
Hum Immunol; 2016 Jan; 77(1):146-152. PubMed ID: 26585777
[TBL] [Abstract][Full Text] [Related]
20. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
